| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.073 | 0.6 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |